Inhibition of xenograft tumor growth in mice by gold nanoparticle-assisted delivery of short hairpin RNAs against Mcl-1L

► We show that a functionalized gold nanoparticle can deliver shRNAs in a mouse model. ► We show that delivery of shRNAs targeted to Mcl-1L gene leads to antitumor activity. ► Our “lego-like” system can load and deliver any sequences of RNA into living systems. A prerequisite for the therapeutic use...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biotechnology 2011-11, Vol.156 (2), p.89-94
Hauptverfasser: Ryou, Sang-Mi, Park, Mira, Kim, Jong-Myung, Jeon, Che Ok, Yun, Cheol-Hui, Han, Seung Hyun, Kim, Si Wouk, Lee, Younghoon, Kim, Sudeok, Han, Min Su, Bae, Jeehyeon, Lee, Kangseok
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► We show that a functionalized gold nanoparticle can deliver shRNAs in a mouse model. ► We show that delivery of shRNAs targeted to Mcl-1L gene leads to antitumor activity. ► Our “lego-like” system can load and deliver any sequences of RNA into living systems. A prerequisite for the therapeutic use of small RNAs is the development of a method that can deliver them into animals. Previous studies have shown the capability of functionalized gold nanoparticles to serve as a general platform for loading and delivering DNA oligonucleotides and short hairpin RNAs (shRNAs) into cultured human cells. Here, we report the ability of the gold nanoparticle-assisted gene delivery system (AuNP-GDS) to deliver shRNA to a xenograft tumor in a mouse model. AuNP-GDS delivery of in vitro synthesized shRNA targeted to the Mcl-1L gene knocked down levels of Mcl-1L mRNA and protein by ∼36% and ∼26%, respectively, which were sufficient to induce apoptosis of the xenograft tumor cells and consequently inhibited the development of the tumor. We demonstrated that our lego-like AuNP-GDS, which can easily load and deliver shRNAs targeted to any gene of interest into living systems, can deliver shRNAs into xenograft tumors, leading to antitumor activity in an animal model.
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2011.07.037